Maternal Dietary Inflammatory Status and Serum Neopterin During Pregnancy: Influence on Infantile Atopic Eczema in the Offspring

IF 4.6 2区 医学 Q2 ALLERGY
Sarah El-Heis, Sarah R. Crozier, Evelyn X. Loo, Elizabeth H. Tham, Nicholas C. Harvey, Hazel M. Inskip, Southampton Women's Survey Study Group, Keith M. Godfrey
{"title":"Maternal Dietary Inflammatory Status and Serum Neopterin During Pregnancy: Influence on Infantile Atopic Eczema in the Offspring","authors":"Sarah El-Heis,&nbsp;Sarah R. Crozier,&nbsp;Evelyn X. Loo,&nbsp;Elizabeth H. Tham,&nbsp;Nicholas C. Harvey,&nbsp;Hazel M. Inskip,&nbsp;Southampton Women's Survey Study Group,&nbsp;Keith M. Godfrey","doi":"10.1002/clt2.70080","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>A protective influence of maternal inflammatory status on infantile atopic eczema risk has been proposed, but few studies have investigated these potential links. We examined the associations between energy-adjusted dietary inflammatory index (E-DII) scores indicative of an inflammatory dietary pattern, maternal serum neopterin levels, a biomarker elevated in Th1 immune activation, and infantile risk of atopic eczema.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Within the UK Southampton Women's Survey, mothers' diets were recorded using questionnaires at preconception, early and late pregnancy and E-DII scores derived. 3006 deliveries of live born infants with no major congenital growth abnormalities who were assessed for atopic eczema at 6 or 12 months (ascertained using the UK Working Party Diagnostic Criteria [<i>n</i> = 2955 and 2871, respectively]). A sub-sample of 497 mothers had serum neopterin measured in late pregnancy.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Unadjusted analyses showed that higher E-DII in preconception and late pregnancy was associated with a lower risk of eczema at ages 6 and 12 months. After adjusting for maternal BMI, age, parity, education, smoking during pregnancy, breastfeeding duration and sex, higher E-DII in late pregnancy was associated with reduced risks of eczema at age 6 and 12 months (OR 0.89 [95% CI 0.81, 0.99], <i>p</i> = 0.03 and OR 0.91 [0.82, 1.00], <i>p</i> = 0.05, respectively). Consistent with this, higher maternal serum neopterin was associated with a lower risk of eczema at ages 6 months (OR 0.72 [0.51, 1.01], <i>p</i> = 0.05) and 12 months (OR 0.71 [0.53, 0.96], <i>p</i> = 0.03).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The findings suggest that a pro-inflammatory maternal diet and an inflammatory maternal environment during pregnancy may protect the developing infant from Th2 driven inflammation and lower the risk of infantile atopic eczema.</p>\n </section>\n \n <section>\n \n <h3> Trial Registration</h3>\n \n <p>NCT04715945</p>\n </section>\n </div>","PeriodicalId":10334,"journal":{"name":"Clinical and Translational Allergy","volume":"15 7","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/clt2.70080","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Allergy","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/clt2.70080","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

A protective influence of maternal inflammatory status on infantile atopic eczema risk has been proposed, but few studies have investigated these potential links. We examined the associations between energy-adjusted dietary inflammatory index (E-DII) scores indicative of an inflammatory dietary pattern, maternal serum neopterin levels, a biomarker elevated in Th1 immune activation, and infantile risk of atopic eczema.

Methods

Within the UK Southampton Women's Survey, mothers' diets were recorded using questionnaires at preconception, early and late pregnancy and E-DII scores derived. 3006 deliveries of live born infants with no major congenital growth abnormalities who were assessed for atopic eczema at 6 or 12 months (ascertained using the UK Working Party Diagnostic Criteria [n = 2955 and 2871, respectively]). A sub-sample of 497 mothers had serum neopterin measured in late pregnancy.

Results

Unadjusted analyses showed that higher E-DII in preconception and late pregnancy was associated with a lower risk of eczema at ages 6 and 12 months. After adjusting for maternal BMI, age, parity, education, smoking during pregnancy, breastfeeding duration and sex, higher E-DII in late pregnancy was associated with reduced risks of eczema at age 6 and 12 months (OR 0.89 [95% CI 0.81, 0.99], p = 0.03 and OR 0.91 [0.82, 1.00], p = 0.05, respectively). Consistent with this, higher maternal serum neopterin was associated with a lower risk of eczema at ages 6 months (OR 0.72 [0.51, 1.01], p = 0.05) and 12 months (OR 0.71 [0.53, 0.96], p = 0.03).

Conclusion

The findings suggest that a pro-inflammatory maternal diet and an inflammatory maternal environment during pregnancy may protect the developing infant from Th2 driven inflammation and lower the risk of infantile atopic eczema.

Trial Registration

NCT04715945

Abstract Image

妊娠期间孕妇饮食炎症状态和血清新蝶呤:对后代婴儿特应性湿疹的影响
母体炎症状态对婴儿特应性湿疹风险的保护作用已被提出,但很少有研究调查这些潜在的联系。我们研究了能量调节饮食炎症指数(E-DII)评分(指示炎症性饮食模式)、母体血清新蝶呤水平(Th1免疫激活的生物标志物升高)和婴儿特应性湿疹风险之间的关系。方法在英国南安普敦妇女调查中,通过孕前、妊娠早期和妊娠晚期的问卷调查记录母亲的饮食,并得出E-DII评分。3006例在6个月或12个月时被评估为特应性湿疹的无重大先天性生长异常的活产婴儿(使用英国工作组诊断标准确定[n = 2955和2871])。497名母亲的亚样本在妊娠后期测量了血清新蝶呤。结果未经调整的分析显示,孕前和妊娠后期较高的E-DII与6个月和12个月时较低的湿疹风险相关。在调整了母亲的BMI、年龄、胎次、受教育程度、孕期吸烟、母乳喂养时间和性别后,妊娠后期较高的E-DII与6个月和12个月时湿疹风险降低相关(OR分别为0.89 [95% CI 0.81, 0.99], p = 0.03和OR为0.91 [0.82,1.00],p = 0.05)。与此一致的是,较高的母体血清新蝶呤与6个月大(OR为0.72 [0.51,1.01],p = 0.05)和12个月大(OR为0.71 [0.53,0.96],p = 0.03)时较低的湿疹风险相关。结论妊娠期促炎母体饮食和炎性母体环境可保护发育中的婴儿免受Th2驱动的炎症,降低婴儿特应性湿疹的风险。试验注册编号NCT04715945
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical and Translational Allergy
Clinical and Translational Allergy Immunology and Microbiology-Immunology
CiteScore
7.50
自引率
4.50%
发文量
117
审稿时长
12 weeks
期刊介绍: Clinical and Translational Allergy, one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology, provides a platform for the dissemination of allergy research and reviews, as well as EAACI position papers, task force reports and guidelines, amongst an international scientific audience. Clinical and Translational Allergy accepts clinical and translational research in the following areas and other related topics: asthma, rhinitis, rhinosinusitis, drug hypersensitivity, allergic conjunctivitis, allergic skin diseases, atopic eczema, urticaria, angioedema, venom hypersensitivity, anaphylaxis, food allergy, immunotherapy, immune modulators and biologics, animal models of allergic disease, immune mechanisms, or any other topic related to allergic disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信